List of SBIR/STTR awards granted to Claremont BioSolutions
Claremont BioSolutionsA SBIR Phase I contract was awarded to Claremont BioSolutions in April, 2019 for $299,988.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to Claremont BioSolutions in September, 2018 for $197,365.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase II contract was awarded to Claremont BioSolutions in May, 2021 for $1,164,571.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to Claremont BioSolutions in September, 2014 for $691,509.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Claremont BioSolutions for $3,000,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Claremont BioSolutions for $609,306.0 USD from the U.S. Department of Health & Human Services.
